Association between bevacizumab administration and delayed wound healing complications before and after central venous port placement in patients with colorectal cancer

Key Points

• Delayed wound healing complications do not appear to be significantly increased by bevacizumab administration.
• Findings indicate low risk associated with peri-central venous port administration of bevacizumab in colorectal cancer patients.
• Observational analysis of colorectal cancer patients provided insights into healing outcomes after port placement.
• Results must be interpreted cautiously, emphasizing the need for further validation of safety.